Nykode Therapeutics’ Post

In this #blog, John McDermott, VP of Scientific Consulting, discusses the benefits of evaluating targeted oncology molecules in healthy volunteers and how our #TranslationalPharmaceutics® platform can help accelerate drug product optimization. Read here: https://bit.ly/3HZLW54

Advancing health outcomes for ALL

Thoughts on this? >> John Carroll on his cancer diagnosis; #ESMO's biggest surprise; Lykos' bad trip; Rate cuts, and more >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma

Drug development can be a risky, expensive journey. With an experienced team of dedicated scientists, we work with our clients to answer their R&D questions and de-risk drug development.🧪💡 Our advanced mathematical models provide invaluable insights, helping you make informed decisions at every stage of the development process, whether it's optimising dosing regimens, identifying potential side effects, or predicting patient response. Our approach minimises reliance on time-consuming lab work and animal studies, ensuring you get it right the first time. Ready to fast-track your path to success? Reach out to our team today! https://lnkd.in/eYmCKgmX #Cancer #DrugDevelopment #CancerDrugs #CancerSimulation #CombinationTherapies #QSP #MathematicalModelling #PKPD #MechanisticModelling #Oncology #ClinicalTrials #ResearchandDevelopment #CancerResearch #BioTech #StatisticalModelling #MachineLearning #Pharma #TranslationalModelling #PYC

After successfully completing Phase II clinical trials for their medication to treat Major Depressive Disorder, ABVC BioPharma Inc (NASDAQ:ABVC). and AiBtl Biopharma Inc. are now embarking on a groundbreaking clinical study focused on Depression in Cancer Patients. This new study will integrate AI-driven solutions to address the significant challenge of depression among cancer patients, a condition that often complicates treatment and adversely affects overall quality of life. Watch at #Proactive #ProactiveInvestors http://ow.ly/eUgT105B3q5

Thoughts on this? >> John Carroll on his cancer diagnosis; #ESMO's biggest surprise; Lykos' bad trip; Rate cuts, and more >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #pharma #productmarketing #healthcare #pharmaceutical

Introducing "Our Stories," a dedicated page that showcases who we are as a company—think of it like a blog, but even better. Here, you'll find compelling narratives about how we make a positive impact on health. From insightful features on our work in biopharma, oncology, and distribution to articles spotlighting the meaningful contributions of our company and employees in fulfilling our mission, "Our Stories" encapsulates it all. Dive into these inspiring stories here: https://lnkd.in/gcE99MYe

Thoughts on this? >> New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #healthcare #productmarketing #biotech

Thoughts on this? >> New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #productmarketing #pharmaceutical #biotech

Accelerating Cancer Drug Development with Predictive Precision Medicine! Predictive precision medicine isn't just about better treatment; it's also about faster drug development. By using ex vivo drug response profiling and advanced algorithms, we can repurpose shelved drugs and identify effective treatments more quickly. This means more personalized therapies and faster access to life-saving medications for patients. #DrugDevelopment #CancerResearch #PrecisionMedicine #HealthcareInnovation #PatientCare https://lnkd.in/gyiMpRAn